U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07379177) titled 'Evaluation of the Pharmacokinetics of Curcumin Capsules in Healthy Human' on Jan. 23.
Brief Summary: Main objective:
Through blood drug concentration testing, evaluate the post-meal pharmacokinetic characteristics of the curcumin product compared to similar products, and assess the differences in body exposure between the self-developed product and the control product in healthy trial participants.
Secondary objective:
Observe the safety of the self-developed product and the control product in healthy trial participants.
Study population:
Healthy male individuals or non-pregnant non-lactating females
Study Start Date: Jan. 28...